Diabetes & Metabolism Journal

Search

Page Path

HOME
Search

Original Articles

Metabolic Risk/Epidemiology

Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study: Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park; Diabetes Metab J. 2023;47(2):220-231. Published online January 12, 2023; DOI: https://doi.org/10.4093/dmj.2021.0327
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Drug/Regimen

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors: Sangmo Hong, Chang Hee Jung, Song Han, Cheol-Young Park; Diabetes Metab J. 2022;46(1):63-70. Published online April 19, 2021; DOI: https://doi.org/10.4093/dmj.2020.0253; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Brief Report

Epidemiology

Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey: Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm; Diabetes Metab J. 2016;40(2):167-170. Published online April 5, 2016; DOI: https://doi.org/10.4093/dmj.2016.40.2.167
Cited By 2; Full text PubReader Crossref - TDM PDF

Volume 47, No. 2

Diabetes &
Metabolism
Journal

Print ISSN: 2233-6079
Online ISSN: 2233-6087

MOST CITED MOST VIEWED

65,535	Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
65,535	Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
65,535	Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
15,948	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
9,870	Insulin Resistance: From Mechanisms to Therapeutic Strategies

Cited By 120	Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
Cited By 81	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
Cited By 48	Treatment of Diabetic Kidney Disease: Current and Future
Cited By 41	Insulin Resistance: From Mechanisms to Therapeutic Strategies
Cited By 37	Hyperinsulinemia in Obesity, Inflammation, and Cancer

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2023 by Korean Diabetes Association.